Background
==========

Initially described by Ariyan in 1979, the PMMC flap has been used to reconstruct oncologic head and neck defects after either primary extirpation or surgical salvage following radiation failure \[[@B1],[@B2]\]. The versatility of the PMMC is evident from its very wide range of use. The flap can be used for defects in the head and neck area including the oral cavity, neck, and maxilla as well as temporo-orbital area \[[@B3]\]. A tube PMMC can also be used to reconstruct the pharynx and the cervical oesophagus. Extending its versatility we present the use of PMMC for mucosal and soft tissue cover in a 4-year-old child.

Case presentation
=================

A 3-year-old boy presented with a large bosselated swelling over the cheek extending to the submandibular, submental, postauricular region and which was still further increasing in size (Figure [1](#F1){ref-type="fig"}). A trucut^®^biopsy was suggestive of fibromatosis. Computerized tomogram (CT) scan revealed a large soft tissue mass infiltrating the massetter, parotid gland, floor mouth, submandibular gland, the lateral oro-nasopharyngeal wall and the pterygoid muscle. The horizontal ramus of mandible was eroded and the mass extended across the midline. Excision of the mass with segmental mandibulectomy was performed. Reconstruction with a free fibula was deferred for a later stage in view of the young age, large mass and concern of recurrent disease. Since the mucosal defect following excision was not large enough primary closure was performed. Histopathology confirmed juvenile fibromatosis and all cut margins of resection were free of tumour. The patient presented after 13 months with recurrent swelling over the cheek with significant difficulty in swallowing and constant dribbling of saliva due to inadequate mouth closure (Figure [2](#F2){ref-type="fig"}). A CT scan revealed presence of a large recurrent mass in the floor of mouth, infiltrating the infratemporal fossa (ITF) and reaching up to the base of skull (Figure [3](#F3){ref-type="fig"}). In view of the extensive recurrence low dose chemotherapy (weekly vinblastine, methotrexate and tamoxifen) was started. After completion of 12 weeks of chemotherapy, a partial response was achieved. Excision of the mass with ITF clearance was performed subsequently. A portion of tongue and its base along with the lateral oropharyngeal and the soft palate was also excised (Figure. [4](#F4){ref-type="fig"}) The defect following resection was large and a free flap was not feasible as the external carotid artery was ligated at previous surgery. Reconstruction with a PMMC flap for providing mucosal cover and soft tissue bulk for defect was considered. In view of the large mucosal defect a large skin paddle was taken incorporating the nipple-areola complex. The technique for harvesting the PMMC has been described previously \[[@B4]\] (Figure [5](#F5){ref-type="fig"}). The edges of the flap were sutured circumferentially to the mucosa of the oral cavity except superiorly where the mucosa was deficient; the flap was anchored to the hard palate with non-absorbable sutures.

![Clinical photograph of the patient at presentation.](1477-7819-5-11-1){#F1}

![Clinical photograph of the patient after recurrence.](1477-7819-5-11-2){#F2}

![A CT scan revealing recurrence at the floor of mouth and presence of tumor in the infratemporal fossa and base of skull.](1477-7819-5-11-3){#F3}

![A&B). Intraoperative photograph revealing the tumor being resected and the surgical defect after excision.](1477-7819-5-11-4){#F4}

![A, B & C). Intraoperative photograph showing the skin paddle of PMMC and its suturing to the surgical defect.](1477-7819-5-11-5){#F5}

Patient had an uneventful recovery and was discharged after ten days. The flap was well taken without any necrosis or other complication. Guide bite prosthesis was used after a week of surgery to prevent malocclusion. Histopathological examination revealed all cut margins to be free of tumour. Patient further received 12 weeks of low dose chemotherapy. At one year follow-up the patient is having normal speech and swallowing and is free from recurrent disease.

Discussion
==========

PMMC flap is a versatile and the most commonly used flap for head and neck reconstruction. Even with the worldwide use of free flaps, they are still the mainstay reconstructive procedures in many centres. In the largest reported series of 500 patients, Milenovic and colleagues reported an overall complication rate of 33%, with only 2% of cases involving total flap necrosis \[[@B5]\]. They concluded that the PMMC flap continues to be the most universal major flap in head and neck reconstruction. Similar observations were made by Vartanian and colleagues in their series of 437 patients \[[@B6]\]. They also observed that the PMMC flap remains an important reconstructive method, and can be done with low risk and acceptable morbidity. Liu and colleagues used PMMC for reconstruction of oral cavity, pharynx, and neck or face as primary reconstructive procedures, or salvage procedures for reconstruction after fistula, flap failure, osteoradionecrosis, and internal jugular vein rupture \[[@B3]\]. In the present case although a free flap reconstruction using a transverse rectus abdominis flap with vascular anastomosis in the opposite neck was deliberated at the second surgery it was considered too extensive for a 4-year-old child hence was deferred. The patient had an excellent recovery with an acceptable cosmesis and function (swallowing, speech, tongue control and oral competence) and is free of disease at one-year follow-up. Although free flaps should be ideally considered in all situations, PMMC can be considered as a reserve in difficult situations and where infrastructural support constrains the liberal use of free flaps.

Conclusion
==========

The PMMC flap is justifiably a popular flap that continues to command an important place in the head and neck surgeon\'s reconstructive armamentarium.
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